Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010

被引：56

作者：

Naito, Seiji ^{[1
]}

Kakehi, Yoshiyuki ^{[1
]}

Okuyama, Akihiko ^{[1
]}

Imamura, Tomoaki ^{[1
]}

Yasunaga, Hideo ^{[1
]}

Akaza, Hideyuki ^{[1
]}

Hinotsu, Shiro ^{[1
]}

Arai, Yoichi ^{[1
]}

Dokiya, Takushi ^{[1
]}

Egawa, Shin ^{[1
]}

Suzuki, Kazuhiro ^{[1
]}

Koga, Hirofumi ^{[1
]}

Masumori, Naoya ^{[1
]}

Akakura, Koichiro ^{[1
]}

Kawashima, Kiyotaka ^{[1
]}

Okihara, Koji ^{[1
]}

Ito, Kazuto ^{[1
]}

机构：

[1] Gunma Univ, Grad Sch, Grad Sch Med, Dept Urol, Gunma 3718511, Japan

来源：

INTERNATIONAL JOURNAL OF UROLOGY | 2010年 / 17卷 / 10期

关键词：

prostate cancer; PSA; screening; guidelines; ACTIVE SURVEILLANCE; UNITED-STATES; PSA VELOCITY; 4.0; NG/ML; RISK; MEN; MORTALITY; STATISTICS; INCREASE; OUTCOMES;

D O I：

10.1111/j.1442-2042.2010.02613.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

The exposure rate of screening for prostate cancer using prostate-specific antigen (PSA) in Japan is still very low compared with that in the USA or western Europe. The mortality rate of prostate cancer will increase in the future and in 2020 it will be 2.8-fold higher than in 2000. Therefore, there is an urgent need to determine the best available countermeasures to decrease the rate of prostate cancer death. PSA screening, which can reduce the risk of death as a result of prostate cancer, should be offered to all men at risk of developing prostate cancer with fact sheets showing updated benefits and drawbacks of screening for prostate cancer.

引用

页码：830 / 838

页数：9

共 50 条

[1] Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan
Ito, Kazuto
Kakehi, Yoshiyuki
Naito, Seiji
Okuyama, Akihiko
[J]. INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (09) : 763 - 768
[2] Prostate-specific antigen-based screening: controversy and guidelines
Kim, Eric H.
Andriole, Gerald L.
[J]. BMC MEDICINE, 2015, 13
[3] Prostate-specific antigen-based screening: controversy and guidelines
Eric H Kim
Gerald L Andriole
[J]. BMC Medicine, 13
[4] Prostate-specific antigen-based prostate cancer screening: Past and future
Alberts, Arnout R.
Schoots, Ivo G.
Roobol, Monique J.
[J]. INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (06) : 524 - 532
[5] Prostate-specific Antigen-Based Screening for Prostate Cancer: The Irony of It All
Carter, H. Ballentine
[J]. EUROPEAN UROLOGY, 2013, 64 (05) : 710 - 711
[6] Re: Prostate-specific antigen-based prostate cancer screening: Past and future
Birkeland, Soren
[J]. INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (04) : 348 - 348
[7] Editorial Comment to Prostate-specific antigen-based prostate cancer screening: Past and future
Sakamoto, Shinichi
[J]. INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (06) : 532 - 533
[8] Prostate-specific antigen-based screening for prostate cancer: Evidence, controversies and future perspectives
Ito, Kazuto
[J]. INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (05) : 458 - 464
[9] Upcoming evidences on prostate-specific antigen-based screening for men at risk of prostate cancer
Boscolo-Berto, Rafael
[J]. INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (09) : 711 - 711
[10] Prostate-specific antigen-based screening for prostate cancer in the third millennium: Useful or hype?
Lippi, Giuseppe
Montagnana, Martina
Guidi, Gian Cesare
Plebani, Mario
[J]. ANNALS OF MEDICINE, 2009, 41 (07) : 480 - 489

← 1 2 3 4 5 →